Valuation: UCB

Market Cap 39.68B 45.5B 37.46B 34.02B 63.74B 4,366B 64.01B 449B 173B 2,220B 171B 167B 7,142B P/E 2026 *
20.8x
P/E 2027 * 17.2x
Enterprise Value 39.98B 45.85B 37.75B 34.28B 64.23B 4,400B 64.5B 452B 175B 2,237B 172B 168B 7,197B EV / Sales 2026 *
4.6x
EV / Sales 2027 * 3.91x
Free-Float
61.59%
Yield 2026 *
0.7%
Yield 2027 * 0.72%
1 day+2.11%
1 week+0.95%
Current month-1.30%
1 month-4.15%
3 months-14.18%
6 months-14.52%
Current year-10.94%
1 week 205.4
Extreme 205.4
213
1 month 200.7
Extreme 200.7
226.2
Current year 200.7
Extreme 200.7
289.5
1 year 191.2
Extreme 191.2
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap. Importance
1/15/26 Exercice

Executive/Senior Manager

3,000 0.0015%
1/15/26 Exercice

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%+0.95%+2.91%+155.47% 45.5B
+0.54%-0.37%+32.76%-3.95% 78.37B
+9.11%+14.20%+530.72%+67.14% 61.5B
+1.54%+6.70%-10.12%-32.11% 59.78B
+0.29%-0.92%-10.95%+26.82% 46.53B
+1.46%+0.60%+55.45%-15.55% 31.84B
+0.76%+3.38%+49.08%+114.79% 25.4B
+6.00%+9.46%+11.24%+166.67% 21.43B
-0.63%-0.80%+57.88%+103.94% 15.77B
-0.65%-8.46%+28.56%+145.68% 13.02B
Average +2.07%+0.75%+74.75%+72.89% 39.92B
Weighted average by Cap. +2.47%+1.35%+97.11%+49.48%

Financials

2026 *2027 *
Net sales 8.69B 9.97B 8.21B 7.46B 13.97B 957B 14.03B 98.34B 37.95B 486B 37.46B 36.62B 1,565B 9.68B 11.1B 9.14B 8.3B 15.55B 1,065B 15.61B 109B 42.24B 541B 41.69B 40.76B 1,742B
Net income 1.93B 2.21B 1.82B 1.66B 3.1B 213B 3.12B 21.84B 8.43B 108B 8.32B 8.13B 348B 2.32B 2.67B 2.2B 1.99B 3.73B 256B 3.75B 26.29B 10.15B 130B 10.01B 9.79B 418B
Net Debt 306M 350M 288M 262M 491M 33.62B 493M 3.46B 1.33B 17.09B 1.32B 1.29B 55B -1.81B -2.07B -1.71B -1.55B -2.9B -199B -2.92B -20.45B -7.89B -101B -7.79B -7.61B -325B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-09-21 212.10 +1.92% 213,832
26-09-18 €208.10 -0.24% 554,518
26-09-17 €208.60 +1.21% 239,037
26-09-16 €206.10 -1.81% 218,006
26-09-15 €209.90 -0.29% 196,985
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
208.10EUR
Average target price
285.00EUR
Spread / Average Target
+36.95%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!